Predictive value of C-reactive protein in patients with unstable angina pectoris undergoing coronary artery stent implantation

Journal of International Medical Research

Volumn 33, Issue 4, 2005, Pages 389-396

  Karaca, I ^a,b   Aydin, K ^a   Yavuzkir, M ^a   Ilkay, E ^a   Akbulut, M ^a   Isik, A ^a   Arslan, N ^a  

^a FIRAT UNIVERSITY   (Turkey)

^b NONE   (Turkey)

Author keywords

C reactive protein (CRP); In stent restenosis; Inflammation

Indexed keywords

3 HYDROXY 3 METHYLGLUTARYL COENZYME A; ACETYLSALICYLIC ACID; ATORVASTATIN; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BIOLOGICAL MARKER; C REACTIVE PROTEIN; ENOXAPARIN; GLYCERYL TRINITRATE; LOW MOLECULAR WEIGHT HEPARIN; NITRATE; TICLOPIDINE;

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; CORONARY ARTERY SPASM; CORONARY RISK; CORONARY STENT; CORRELATION ANALYSIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; FEMALE; FOLLOW UP; HUMAN; IN-STENT RESTENOSIS; MAJOR CLINICAL STUDY; MALE; PREDICTION; SIDE EFFECT; TRANSLUMINAL CORONARY ANGIOPLASTY; TREATMENT OUTCOME; UNSTABLE ANGINA PECTORIS;

EID: 23044490869     PISSN: 03000605     EISSN: None     Source Type: Journal    
DOI: 10.1177/147323000503300404     Document Type: Article

References (24)

1. Alexander RW: Inflammation and coronary artery disease. N Engl J Med 1994; 331: 468-469.
2. Ross R, Glomset JA: The pathogenesis of atherosclerosis. N Engl J Med 1976; 295: 369-377.
3. Ross R: The pathogenesis of atherosclerosis - an update. N Engl J Med 1986; 314: 488-500.
4. Ross R: The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 1993; 362: 801-809.
5. Ross R: Atherosclerosis - an inflammatory disease. N Engl J Med 1999; 340: 115-126.
6. Toss H, Lindahl B, Siegbahn A, Wallentin L: Prognostic influence of increased fibrinogen and C-reactive protein values in unstable coronary artery disease. FRISC Study Group. Fragmin during instability in coronary artery disease. Circulation 1997; 96: 4204-4210.
7. Liuzzo G, Biasucci LM, Gallimore JR, Grillo RL, Rebuzzi AG, Pepys MB, et al: The prognostic value of C-reactive protein and serum amyloid A protein in severe unstable angina. N Engl J Med 1994; 331: 417-424.
8. Pepys MB: The acute phase response and C-reactive protein: In: Oxford Textbook of Medicine, 3rd edn (Weatherall DJ, Ledingham JGG, Warrell DA, eds). New York: Oxford University Press, 1995; pp1527-1533.
9. Liuzzo G, Buffon A, Biasucci LM, Gallimore JR, Caligiuri G, Vitelli A, et al: Enhanced inflammatory response to coronary angioplasty in patients with severe unstable angina. Circulation 1998; 98: 2370-2376.
10. Gaspardone A, Crea F, Versaci F, Tomai F, Pellegrino A, Chiariello L, et al: Predictive value of C-reactive protein after successful coronary artery stenting in patients with stable angina. Am J Cardiol 1998; 82: 515-518.
11. Azar RR, McKay RG, Kiernan FJ, Seecharran B, Feng YJ, Fram DB, et al: Coronary angioplasty induces a systemic inflammatory response. Am J Cardiol 1997; 80: 1476-1478.
12. Donal E, Allal J, Christiaens L, Lecron JC, Ragot S, Coisne D: Systemic markers of inflammation after coronary angioplasty. Presse Med 2001; 30: 1701-1705.
13. Tomoda H, Aoki N: Instability of coronary lesions in unstable angina assessed by C-reactive protein values following coronary interventions. Am J Cardiol 2001; 87: 221-223.
14. Walter DH, Fichtlscherer S, Sellwig M, Auch-Schwelk W, Schachinger V, Zeiher AM: Preprocedural C-reactive protein values and cardiovascular events after coronary stent implantation. J Am Coll Cardiol 2001; 37: 839-846.
15. Braunwald E: Unstable angina: a classification. Circulation 1989; 80: 410-414.
16. Davidson CJ, Bonow RO: The Judkins Technique. Left heart catheterization and coronary arteriography. Cardiac catheterization. In: Heart Disease, 6th edn (Braunwald E, ed). Philadelphia: WB Saunders Company, 2001; p367.
17. Ryan TJ, Bauman WB, Kennedy JW, Kereiakes DJ, King SB, 3rd, McCallister BD, et al: Guidelines for percutaneous transluminal coronary angioplasty. A report of the American Heart Association/American College of Cardiology Task Force on Assessment of Diagnostic and Therapeutic Cardiovascular Procedures (Committee on Percutaneous Transluminal Coronary Angioplasty). Circulation 1993; 88: 2987-3007.
18. Robbins M, Topol EJ: Inflammation in acute coronary syndromes. In: Acute Coronary Syndromes, 2nd edn (Topol EJ, ed). New York: Marcel Dekker AG, 2001; pp1-31.
19. Liao F, Andalibi A, deBeer FC, Fogelman AM, Lusis AJ: Genetic control of inflammatory gene induction and NF-kappa B-like transcription factor activation in response to an atherogenic diet in mice. J Clin Invest 1993; 91: 2572-2579.
20. van der Wal AC, Becker AE, van der Loos CM, Das PK: Site of intimal rupture or erosion of thrombosed coronary atherosclerotic plaques is characterized by an inflammatory process irrespective of the dominant plaque morphology. Circulation 1994; 89: 36-44.
21. Moreno PR, Falk E, Palacios IF, Newell JB, Fuster V, Fallon JT: Macrophage infiltration in acute coronary syndrome: implications for plaque rupture. Circulation 1994; 90: 775-778.
22. Santamaria P, Gehrz RC, Bryan MK, Barbosa JJ: Involvement of class II MHC molecules in the LPS induction of IL-1/TNF secretions by human monocytes. Quantitative differences at the polymorphic value. J Immunol 1989; 143: 913-922.
23. Versaci F, Gaspardone A, Tomai F, Crea F, Chiariello L, Gioffre PA: Predictive value of C-reactive protein in patients with unstable angina pectoris undergoing coronary artery stent implantation. Am J Cardiol 2000; 85: 92-95.
24. Gottsauner-Wolf M, Zasmeta G, Hornykewycz S, Nikfardjam M, Stepan E, Wexberg P, et al: Plasma values of C-reactive protein after coronary stent implantation. Eur Heart J 2000; 21: 1152-1158.